![]() |
Lung Cancer |
Free Subscription
1 AJR Am J Roentgenol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Lung Cancer is free of charge.
Scrutinizing the Benefits of Artificial Intelligence Nodule Detection in Lung
Cancer Screening.
AJR Am J Roentgenol. 2025 Apr 30. doi: 10.2214/AJR.25.33134.
PubMed
Tumor Cellularity Assessment Using Artificial Intelligence Trained on
Immunohistochemistry-Restained Slides Improves Selection of Lung Adenocarcinoma
Samples for Molecular Testing.
Am J Pathol. 2025;195:907-922.
PubMed
Abstract available
Enhanced Galphaq Signaling in TSC2-Deficient Cells Is Required for Their Neoplastic
Behavior.
Am J Respir Cell Mol Biol. 2025;72:578-590.
PubMed
Abstract available
A randomised phase III study of bevacizumab and carboplatin-pemetrexed
chemotherapy with or without atezolizumab as first-line treatment for advanced
pleural mesothelioma: results of the ETOP 13-18 BEAT-meso trial.
Ann Oncol. 2025;36:548-560.
PubMed
Abstract available
Difficult Decisions in the Multidisciplinary Treatment of Resectable Non-small
Cell Lung Cancer.
Ann Surg Oncol. 2025 Apr 28. doi: 10.1245/s10434-025-17345.
PubMed
Abstract available
Lobectomy vs Sublobar Resection in The Society of Thoracic Surgeons Database:
Importance of Patient Factors and Lymph Node Evaluation.
Ann Thorac Surg. 2025;119:1071-1081.
PubMed
Abstract available
Efficacy and Prognostic Factors of Surgical Resection for Pulmonary Metastases
From Ovarian Cancer.
Anticancer Res. 2025;45:2071-2078.
PubMed
Abstract available
Expression of YAP1 and TAZ in Melanoma-, Bronchial- and Breast Carcinoma Brain
Metastasis: Primary vs. Relapsed Tumors.
Anticancer Res. 2025;45:1807-1812.
PubMed
Abstract available
Recombinant Methioninase and Cisplatinum Act Synergistically to Inhibit Lewis
Lung Carcinoma Cells But Not Normal Fibroblasts.
Anticancer Res. 2025;45:1871-1876.
PubMed
Abstract available
Elevated PD-L1 Expression on Circulating Classical Monocytes Upon Checkpoint
Inhibitor Therapy Is Associated With Increased Plasma Interleukin 5 in Patients
With Lung Cancer.
Anticancer Res. 2025;45:1915-1925.
PubMed
Abstract available
SH003 Inhibits Proliferation and Induces Apoptosis in NSCLC Cell Lines by
Inhibiting the Receptor Tyrosine Kinase-related Pathway.
Anticancer Res. 2025;45:1981-1995.
PubMed
Abstract available
Immune Checkpoint Biomarkers Galectin-9 and TIM-3 Predict Melanoma and Lung
Cancer Mortality in Obstructive Sleep Apnoea.
Arch Bronconeumol. 2025 Apr 2:S0300-2896(25)00116.
PubMed
Abstract available
The association of PD-L1 expression status and the PD-1/PD-L1 inhibitor-related
toxicity profile in non-small cell lung cancer.
BMC Cancer. 2025;25:799.
PubMed
Abstract available
Thyroid dysfunction as a predictor of PD- 1/PD-L1 inhibitor efficacy in advanced
lung cancer.
BMC Cancer. 2025;25:791.
PubMed
Abstract available
Comprehensive pan-cancer analysis of CHRDL1 and experimental validation of its
role in lung adenocarcinoma.
BMC Cancer. 2025;25:783.
PubMed
Abstract available
The real-world safety profile of pemetrexed and platinum with or without
pembrolizumab: insights from a comparative analysis of FAERS database.
BMC Cancer. 2025;25:767.
PubMed
Abstract available
Machine learning in prediction of epidermal growth factor receptor status in
non-small cell lung cancer brain metastases: a systematic review and
meta-analysis.
BMC Cancer. 2025;25:818.
PubMed
Abstract available
Combined effect of areca nut, cigarettes, alcohol and SNPs in glycosyltransferase
family genes on lung cancer development in Hainan, China.
BMC Cancer. 2025;25:814.
PubMed
Abstract available
Sex-related differences in postoperative patient-reported outcomes among lung
cancer patients: a multicenter cohort study.
BMC Cancer. 2025;25:800.
PubMed
Abstract available
Artificial intelligence-driven microsatellite instability profiling reveals
distinctive genetic features in patients with lung cancer.
Cancer. 2025;131:e35882.
PubMed
Abstract available
The Glycosyltransferase XYLT1 Activates NF-kappaB Signaling to Promote Metastasis of
Early-Stage Lung Adenocarcinoma.
Cancer Res. 2025;85:1628-1643.
PubMed
Abstract available
The Biology in the Pattern: Metastatic Organotropism and Clinical Outcome Depend
on DNA Damage Response and Immune Interactions in Pancreatic Cancer.
Cancer Res. 2025;85:1571-1573.
PubMed
Abstract available
The Lung Cancer Autochthonous Model Gene Expression Database Enables Cross-Study
Comparisons of the Transcriptomic Landscapes Across Mouse Models.
Cancer Res. 2025 Apr 29:OF1-OF15. doi: 10.1158/0008-5472.CAN-24-1607.
PubMed
Abstract available
Loss of Tapasin in Tumors Potentiates T-Cell Recognition and Anti-Tumor Effects
of Immune Checkpoint Blockade.
Cancer Sci. 2025;116:1203-1213.
PubMed
Abstract available
Novel Approach to Overcome Osimertinib Resistance Using Bromodomain and
Extra-Terminal Domain Inhibitors.
Cancer Sci. 2025;116:1392-1404.
PubMed
Abstract available
Antibody Drug Conjugates in Non-Small Cell Lung Cancer: Where is the Target and
the Biomarker?
Clin Cancer Res. 2025 Apr 28. doi: 10.1158/1078-0432.CCR-25-0839.
PubMed
Abstract available
Amplification of extrachromosomal MYC paralogs shapes immunosuppressive tumor
microenvironment in small cell lung cancer.
Clin Cancer Res. 2025 Apr 29. doi: 10.1158/1078-0432.CCR-24-3399.
PubMed
Abstract available
Surgical and Pathological Results Following Neoadjuvant Nivolumab and
Platinum-Based Chemotherapy for Locally Advanced Resectable NSCLC: A Multicentre
Real-World Series From England.
Clin Lung Cancer. 2025;26:253-261.
PubMed
Abstract available
Computer Assisted Nodule Analysis and Risk Yield is Associated With Occult Lymph
Node Status in Clinical Stage I-IIA Lung Adenocarcinoma Undergoing Resection.
Clin Lung Cancer. 2025;26:e142-e149.
PubMed
Abstract available
Real-World Outcomes of Tarlatamab in Small Cell Lung Cancer, Including Patients
With Untreated Brain Metastases.
Clin Lung Cancer. 2025 Mar 26:S1525-7304(25)00052.
PubMed
Abstract available
Elucidating the Role of EGFR(L858R) in Brain Metastasis Among Patients With
Advanced NSCLC Undergoing TKI Therapy.
Clin Lung Cancer. 2025;26:e199-e206.
PubMed
Abstract available
Imaging Findings Related to Lung Tract Sealant Use in Percutaneous CT-guided Lung
Biopsy.
Clin Lung Cancer. 2025;26:236-243.
PubMed
Abstract available
Kirsten Rat Sarcoma Virus Mutations Effect On Tumor Doubling Time And Prognosis
Of Solid Dominant Stage I Lung Adenocarcinoma.
Clin Lung Cancer. 2025;26:210-220.
PubMed
Abstract available
Prognostic Analysis of Pathological Stage I Lung Adenocarcinoma Harboring Major
EGFR Mutations.
Clin Lung Cancer. 2025;26:e172-e180.
PubMed
Abstract available
Letter Re: Five-year outcomes with first-line nivolumab plus ipilimumab with 2
cycles of chemotherapy versus 4 cycles of chemotherapy alone in patients with
metastatic non-small cell lung cancer in the randomized CheckMate 9LA trial.
Eur J Cancer. 2025 Apr 23:115442. doi: 10.1016/j.ejca.2025.115442.
PubMed
Correlation between irAEs and survival outcomes in patients with ES-SCLC treated
with first-line chemoimmunotherapy.
Eur J Cancer. 2025;221:115435.
PubMed
Abstract available
Current perspective on resectability in stage III locally advanced NSCLC - The
thoracic surgeons' view.
Eur J Cancer. 2025;221:115426.
PubMed
Abstract available
Prognosis of adenocarcinoma with innumerable pure ground-glass nodules and/or
part-solid nodules.
Eur J Cardiothorac Surg. 2025;67:ezaf130.
PubMed
Abstract available
Let's talk about sex: Survival among females and males in a real-world cohort
treated with pembrolizumab for non-small cell lung cancer.
Int J Cancer. 2025 Apr 29. doi: 10.1002/ijc.35445.
PubMed
Abstract available
Furmonertinib in uncommon EGFR-mutated non-small cell lung cancer with central
nervous system metastases: A retrospective cohort study.
Int J Cancer. 2025 Apr 29. doi: 10.1002/ijc.35460.
PubMed
Abstract available
International Patterns of Practice for Stereotactic Ablative Radiotherapy for
Early-Stage Non-Small Cell Lung Cancer: Are We All in Sync?: Global patterns of
practice for SABR for early-stage NSCLC.
Int J Radiat Oncol Biol Phys. 2025 Apr 29:S0360-3016(25)00390.
PubMed
Abstract available
Every Patient Is Unique and Deserves the Best: The Present and Future Treatment
Landscape of Uncommon Epidermal Growth Factor Receptor Mutations in Non-Small
Cell Lung Cancer.
J Clin Oncol. 2025 Apr 25:JCO2500625. doi: 10.1200/JCO-25-00625.
PubMed
Perfusion Strategies for Cytoreductive Surgery With Heated Intraperitoneal
Chemotherapy for Malignant Peritoneal Mesothelioma.
J Surg Oncol. 2025;131:310-315.
PubMed
Abstract available
Extent of Resection in Surgically Resected Stage IV Non-Small-Cell Lung Cancer:
Results from Two Tertiary Referral Centers.
J Thorac Cardiovasc Surg. 2025 Apr 23:S0022-5223(25)00327.
PubMed
Abstract available
Outcome of temozolomide in relapsed small cell lung cancer: A retrospective
single center analysis.
Lung Cancer. 2025;203:108539.
PubMed
Abstract available
Amivantamab plus lazertinib versus osimertinib as first-line treatment in
EGFR-mutated advanced non-small cell lung cancer: MARIPOSA Asian subset.
Lung Cancer. 2025;204:108496.
PubMed
Abstract available
Clinical effect of pulmonary rehabilitation during radiotherapy in lung cancer: A
randomized controlled trial.
Lung Cancer. 2025;204:108546.
PubMed
Abstract available
Beyond environmental risk: Genetic insights into lung cancer susceptibility
through whole exome analysis.
Lung Cancer. 2025;204:108560.
PubMed
Abstract available
Prevalence of EGFR Mutations in Vietnamese Patients with Resected Early Stage
Non-Small Cell Lung Cancer: EARLY-EGFR Study.
Lung Cancer (Auckl). 2025;16:39-49.
PubMed
Abstract available
PLK4 inhibition as a strategy to enhance non-small cell lung cancer
radiosensitivity.
Mol Cancer Ther. 2025 Apr 29. doi: 10.1158/1535-7163.MCT-24-0978.
PubMed
Abstract available
The anti-FRalpha antibody-drug conjugate luveltamab tazevibulin demonstrates efficacy
in non-small cell lung cancer preclinical models and induces immunogenic cell
death.
Mol Cancer Ther. 2025 Apr 28. doi: 10.1158/1535-7163.MCT-24-0649.
PubMed
Abstract available
Zongertinib in Previously Treated HER2-Mutant Non-Small-Cell Lung Cancer.
N Engl J Med. 2025 Apr 28. doi: 10.1056/NEJMoa2503704.
PubMed
Abstract available
SETD5 facilitates stemness and represses ferroptosis via m6A-mediating PKM2
stabilization in non-small cell lung cancer.
Oncogene. 2025 Apr 30. doi: 10.1038/s41388-025-03426.
PubMed
Abstract available
Optimizing chemotherapeutic targets in non-small cell lung cancer with transfer
learning for precision medicine.
PLoS One. 2025;20:e0319499.
PubMed
Abstract available
Development of a nomogram for overall survival prediction in primary upper lobe
lung cancer patients: A SEER population-based analysis.
PLoS One. 2025;20:e0321955.
PubMed
Abstract available
Survival assessment and pre-diagnostic risk factors for lung cancer incidence:
Insights from the Golestan Cohort Study.
PLoS One. 2025;20:e0320931.
PubMed
Abstract available
Thank you for your interest in scientific medicine.